Search research articles
Contact Us
Filters
Showing results (21-30 of 114) with videos related to
Page
of 12
Sort By:
Journal of Hematology & Oncology
|
May 4, 2018
First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
Weili Sun, Huaying Liu, Young Kim, et al.
Leukemia & Lymphoma
|
May 21, 2025
Comparison of CALGB 10403 and HyperCVAD in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia in adults ≥40 years old
Purav Mehta, Dat Ngo, Jose Tinajero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 1, 2006
Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation
Jeffrey Y C Wong, An Liu, Timothy Schultheiss, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2012
Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation
Jeffrey Y C Wong, Stephen Forman, George Somlo, et al.
International Journal of Molecular Sciences
|
May 25, 2024
<i>BRAF</i> Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis Experience
Fei Fei, Caitlin Caporale, Lisa Chang, et al.
Journal of Medical Economics
|
June 21, 2017
Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective
Thomas E Delea, Jordan Amdahl, Diana Boyko, et al.
Blood
|
March 27, 2014
Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells
Amy M Cook, Liang Li, Yinwei Ho, et al.
Blood
|
May 10, 2018
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
Max S Topp, Zachary Zimmerman, Paul Cannell, et al.
Drug Safety
|
December 20, 2018
Benefit-Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Anthony Stein, Janet L Franklin, Victoria M Chia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 15, 2014
Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation
Ji Hyun Kim, Anthony Stein, Nicole Tsai, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 114) with videos related to
Sort By:
Page
of 12
Journal of Hematology & Oncology
|
May 4, 2018
First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
Weili Sun, Huaying Liu, Young Kim, et al.
Leukemia & Lymphoma
|
May 21, 2025
Comparison of CALGB 10403 and HyperCVAD in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia in adults ≥40 years old
Purav Mehta, Dat Ngo, Jose Tinajero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 1, 2006
Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation
Jeffrey Y C Wong, An Liu, Timothy Schultheiss, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2012
Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation
Jeffrey Y C Wong, Stephen Forman, George Somlo, et al.
International Journal of Molecular Sciences
|
May 25, 2024
<i>BRAF</i> Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis Experience
Fei Fei, Caitlin Caporale, Lisa Chang, et al.
Journal of Medical Economics
|
June 21, 2017
Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective
Thomas E Delea, Jordan Amdahl, Diana Boyko, et al.
Blood
|
March 27, 2014
Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells
Amy M Cook, Liang Li, Yinwei Ho, et al.
Blood
|
May 10, 2018
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
Max S Topp, Zachary Zimmerman, Paul Cannell, et al.
Drug Safety
|
December 20, 2018
Benefit-Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Anthony Stein, Janet L Franklin, Victoria M Chia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 15, 2014
Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation
Ji Hyun Kim, Anthony Stein, Nicole Tsai, et al.
Page
of 12